Jun Ikari

987 citations

50 papers · 701 indexed · h-index 16

Impact in

Microbiology top 2%
Pulmonary and Respiratory Medicine top 10%
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Respiratory Support and Mechanisms
- Lung Cancer Diagnosis and Treatment

Papers in ⓘ

Pulmonary and Respiratory Medicine 38
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 16
- Chronic Obstructive Pulmonary Disease (COPD) Research 16
- Pulmonary Hypertension Research and Treatments 7
- Respiratory Support and Mechanisms 6
- Lung Cancer Diagnosis and Treatment 6
- Tracheal and airway disorders 3
Physiology 10
- Asthma and respiratory diseases 5

Co-authors: Koichiro Tatsumi (37 shared papers)Stephen I. Rennard (7 shared papers)Masaki Suzuki (10 shared papers)Joel Michalski (3 shared papers)Naoko Kawata (16 shared papers)Nozomi Tanaka (6 shared papers)Ayako Shimada (6 shared papers)Eiko Suzuki (7 shared papers)
Journals: International Journal of COPD (4 papers)PLoS ONE (4 papers)American Journal of Respiratory Cell and Molecular Biology (3 papers)In Vitro Cellular & Developmental Biology - Animal (2 papers)Drug Design Development and Therapy (2 papers)
Partner nations: Japan United States Germany

In The Last Decade

Jun Ikari

49 papers receiving 687 citations

Peers

Countries citing papers authored by Jun Ikari

Since Specialization

Citations

This map shows the geographic impact of Jun Ikari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ikari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ikari more than expected).

Fields of papers citing papers by Jun Ikari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ikari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ikari. The network helps show where Jun Ikari may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Ikari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Ikari Line = papers co-authored together Jun Ikari links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	PAD4 Deficiency Improves Bleomycin-induced Neutrophil Extracellular Traps and Fibrosis in Mouse Lung American Journal of Respiratory Cell and Molecular Biology ·Masaki Suzuki, Jun Ikari, Rie Anazawa, Nozomi Tanaka, Yusuke Katsumata, Ayako Shimada, Eiko Suzuki, Koichiro Tatsumi	2020	97
2	Vitamin D Modulates Prostaglandin E2 Synthesis and Degradation in Human Lung Fibroblasts American Journal of Respiratory Cell and Molecular Biology ·Xiangde Liu, Amy Nelson, Xingqi Wang, Maha Farid, Yoko Gunji, Jun Ikari, Shun Iwasawa, Hesham Basma, Carol Feghali‐Bostwick, Stephen I. Rennard	2013	66
3	PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease Clinical Pharmacology & Therapeutics ·Joel Michalski, Gregory A. Golden, Jun Ikari, Stephen I. Rennard	2011	65
4	Clinical characteristics of pulmonary nocardiosis in immunocompetent patients Journal of Infection and Chemotherapy ·Tetsuo Fujita, Jun Ikari, Akira Watanabe, Koichiro Tatsumi	2016	40
5	Clinical, physiological, and radiological features of asthma–chronic obstructive pulmonary disease overlap syndrome International Journal of COPD ·Yuji Tada, Toshio Suzuki, Naoko Kawata, Yukiko Matsuura, Jun Ikari, Yasunori Kasahara, Koichiro Tatsumi	2015	35
6	Endothelial-to-mesenchymal transition in lipopolysaccharide-induced acute lung injury drives a progenitor cell-like phenotype American Journal of Physiology-Lung Cellular and Molecular Physiology ·Toshio Suzuki, Yuji Tada, Rintaro Nishimura, Takeshi Kawasaki, Ayumi Sekine, Takashi Urushibara, Fumiaki Kato, T. Kinoshita, Jun Ikari, James West, Koichiro Tatsumi	2016	26
7	Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study Drug Design Development and Therapy ·Kenji Tsushima, Mitsuhiro Abe, Takuma Matsumura, Tsukasa Ishiwata, Yasunori Ichimura, Jun Ikari, Jiro Terada, Yuji Tada, Seiichirou Sakao, Nobuhiro Tanabe, Koichiro Tatsumi	2015	23
8	Longitudinal changes in structural abnormalities using MDCT in COPD: do the CT measurements of airway wall thickness and small pulmonary vessels change in parallel with emphysematous progression? International Journal of COPD ·Shin Takayanagi, Naoko Kawata, Yuji Tada, Jun Ikari, Yukiko Matsuura, Shin Matsuoka, Shoichiro Matsushita, Noriyuki Yanagawa, Yasunori Kasahara, Koichiro Tatsumi	2017	21
9	Smad3 mediates cigarette smoke extract (CSE) induction of VEGF release by human fetal lung fibroblasts Toxicology Letters ·Maha Farid, Nobuhiro Kanaji, Masanori Nakanishi, Yoko Gunji, Joel Michalski, Shunichiro Iwasawa, Jun Ikari, Xingqi Wang, Hesham Basma, Amy Nelson, Xiangde Liu, Stephen I. Rennard	2013	21
10	Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease PLoS ONE ·Jun Ikari, Amy Nelson, Jannah M. Obaid, Álvaro Girón-Martínez, Kumiko Ikari, Fumihiko Makino, Shunichiro Iwasawa, Yoko Gunji, Maha Farid, Xingqi Wang, Hesham Basma, Dawn L. DeMeo, Carol Feghali‐Bostwick, Olaf Holz, Klaus F. Rabe, Xiangde Liu, Stephen I. Rennard	2017	18
11	Comprehensive lipid profiling of bleomycin‐induced lung injury Journal of Applied Toxicology ·Kosuke Saito, Nozomi Tanaka, Jun Ikari, Masaki Suzuki, Rie Anazawa, Mitsuhiro Abe, Yoshiro Saito, Koichiro Tatsumi	2018	18
12	Effect of culture conditions on microRNA expression in primary adult control and COPD lung fibroblasts in vitro In Vitro Cellular & Developmental Biology - Animal ·Jun Ikari, Lynette M. Smith, Amy Nelson, Shunichiro Iwasawa, Yoko Gunji, Maha Farid, Xingqi Wang, Hesham Basma, Carol Feghali‐Bostwick, Xiangde Liu, Dawn L. DeMeo, Stephen I. Rennard	2014	18
13	Efficacy of End-Tidal Capnography Monitoring during Flexible Bronchoscopy in Nonintubated Patients under Sedation: A Randomized Controlled Study Respiration ·Tsukasa Ishiwata, Kenji Tsushima, Jiro Terada, Mai Fujie, Mitsuhiro Abe, Jun Ikari, Naoko Kawata, Yuji Tada, Koichiro Tatsumi	2018	16
14	Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study Drug Design Development and Therapy ·Mitsuhiro Abe, Kenji Tsushima, Masashi Sakayori, Kenichi Suzuki, Jun Ikari, Jiro Terada, Koichiro Tatsumi	2018	16
15	Bcl6 in pulmonary epithelium coordinately controls the expression of the CC‐type chemokine genes and attenuates allergic airway inflammation Clinical & Experimental Allergy ·Takumi Seto, Masuhiro Yoshitake, Takashi Ogasawara, Jun Ikari, Akemi Sakamoto, Masahiko Hatano, Hirokuni Hirata, Takeshi Fukuda, T Kuriyama, Koichiro Tatsumi, T Tokuhisa, Masafumi Arima	2011	15
16	A Case of IgG4-related Lung Disease Associated with Multicentric Castleman's Disease and Lung Cancer Internal Medicine ·Jun Ikari, Masaru Kojima, Kazuhiro Tomita, Tõru Nakamura, Futoru Toyoda, Yoshiro Otsuki, Shinichi Shimizu, Hiroshi Kobayashi, Hidenori Nakamura	2010	15
17	Transcriptomic changes involved in the dedifferentiation of myofibroblasts derived from the lung of a patient with idiopathic pulmonary fibrosis Molecular Medicine Reports ·Kenichi Suzuki, Jun‐Dal Kim, Keita Ugai, Shuichi Matsuda, Hideki Mikami, Kento Yoshioka, Jun Ikari, Masahiko Hatano, Akiyoshi Fukamizu, Koichiro Tatsumi, Yoshitoshi Kasuya	2020	15
18	Development of chronic allergic responses by dampening Bcl6-mediated suppressor activity in memory T helper 2 cells Proceedings of the National Academy of Sciences ·Takashi Ogasawara, Masahiko Hatano, Hisae Satake, Jun Ikari, Toshibumi Taniguchi, N Tsuruoka, Haruko Watanabe‐Takano, Lisa Fujimura, Akemi Sakamoto, Hirokuni Hirata, Kumiya Sugiyama, Yasutsugu Fukushima, Susumu Nakae, Kenji Matsumoto, Hirohisa Saito, Takeshi Fukuda, Kazuhiro Kurasawa, Koichiro Tatsumi, Takeshi Tokuhisa, Masafumi Arima	2017	13
19	Feasibility and accuracy of rapid on-site evaluation of touch imprint cytology during transbronchial biopsy Journal of Thoracic Disease ·Kohei Shikano, Tsukasa Ishiwata, Fumie Saegusa, Jiro Terada, Masashi Sakayori, Mitsuhiro Abe, Takeshi Kawasaki, Jun Ikari, Naoko Kawata, Yuji Tada, Koichiro Tatsumi	2020	12
20	The Relationship of Bone Mineral Density in Men with Chronic Obstructive Pulmonary Disease Classified According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) Combined Chronic Obstructive Pulmonary Disease (COPD) Assessment System Internal Medicine ·Yoriko Sakurai-Iesato, Naoko Kawata, Yuji Tada, Ken Iesato, Yukiko Matsuura, Misuzu Yahaba, Toshio Suzuki, Jun Ikari, Noriyuki Yanagawa, Yasunori Kasahara, James West, Koichiro Tatsumi	2017	12

About Jun Ikari

Jun Ikari is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Molecular Biology, Epidemiology and Immunology, having authored 50 papers that have together received 701 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Pulmonary Hypertension Research and Treatments (7 papers), Respiratory Support and Mechanisms (6 papers), Lung Cancer Diagnosis and Treatment (6 papers), Asthma and respiratory diseases (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers) and Tracheal and airway disorders (3 papers). The work is most often cited by research in Microbiology (38 citations), Pulmonary and Respiratory Medicine (331 citations), Physiology (156 citations), Immunology (113 citations) and Small Animals (35 citations). Jun Ikari has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Koichiro Tatsumi, Stephen I. Rennard, Masaki Suzuki, Joel Michalski, Naoko Kawata, Nozomi Tanaka, Ayako Shimada, Eiko Suzuki, Yuji Tada and Mitsuhiro Abe. Their work appears in journals such as International Journal of COPD, PLoS ONE, American Journal of Respiratory Cell and Molecular Biology, In Vitro Cellular & Developmental Biology - Animal and Drug Design Development and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact